SCHEMBL29472500

SCHEMBL29472500

CN(C)CCOc1ccc(CCNC(=O)/C=C/c2ccc(O)c(O)c2)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 3/20 0.65
MMP1 P03956 2/20 0.62
MMP2 P08253 2/20 0.62
MMP9 P14780 2/20 0.62
ARG1 P05089 1/20 0.62
ACHE P22303 3/20 0.59
TYR P14679 1/20 0.59
BCHE P06276 1/20 0.56
MAOA P21397 1/20 0.53
MAOB P27338 1/20 0.53
CA12 O43570 1/20 0.53
CA1 P00915 1/20 0.53
CA4 P22748 1/20 0.53
CA6 P23280 1/20 0.53
CA5A P35218 1/20 0.53
CA7 P43166 1/20 0.53
CA9 Q16790 1/20 0.53
CA14 Q9ULX7 1/20 0.53
CA5B Q9Y2D0 1/20 0.53
MAPT P10636 3/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25311354 1.00 APP (0.65) APPMMP1MMP2MMP9ARG1
SCHEMBL29472464 0.88 APP (0.67) APPMMP1MMP2MMP9ARG1
SCHEMBL29069169 0.88 APP (0.67) APPMMP1MMP2MMP9ARG1
SCHEMBL29472471 0.87 APP (0.70) APPMMP1MMP2MMP9ARG1
SCHEMBL23294911 0.87 APP (0.70) APPMMP1MMP2MMP9ARG1
SCHEMBL28809939 0.87 APP (0.66) APPMMP1MMP2MMP9ARG1
SCHEMBL29472465 0.87 APP (0.66) APPMMP1MMP2MMP9ARG1
SCHEMBL25310701 0.87 APP (0.66) APPMMP1MMP2MMP9ARG1
SCHEMBL29472467 0.87 APP (0.66) APPMMP1MMP2MMP9ARG1
SCHEMBL25310470 0.86 APP (0.72) APPMMP1MMP2MMP9ARG1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4228667-A1 METHODS FOR REVERSING HEPATIC STEATOSIS Brightseed, Inc. (US) 2023-08-23 EP claimed
CN-116568319-A Method for reversing hepatic steatosis 布莱特西德公司 2023-08-08 CN claimed
EP-4048655-A1 RECOMBINANT CELL, EXTRACT, CONSUMABLE PRODUCT AND METHOD FOR PRODUCTION OF BIOACTIVE PLANT METABOLITE Brightseed, Inc. (US) 2022-08-31 EP claimed
CN-114929033-A Methods for improving digestive health 布莱特西德公司 2022-08-19 CN claimed
CN-114901630-A Recombinant cells, extracts, consumable products and methods for producing bioactive plant metabolites 布莱特西德公司 2022-08-12 CN claimed
EP-4003060-A1 METHOD FOR IMPROVING DIGESTIVE HEALTH Brightseed, Inc. (US) 2022-06-01 EP claimed
WO-2022081567-A1 METHODS FOR REVERSING HEPATIC STEATOSIS BRIGHTSEED, INC. (US) 2022-04-21 WO claimed
EP-4590287-A1 COMPOSITIONS AND METHODS FOR IMPROVING GUT PERMEABILITY Brightseed, Inc. (US) 2025-07-30 EP disclosed
EP-4465976-A1 USES AND METHODS FOR PROMOTING INCREASED MITOCHONDRIAL MASS AND FUNCTION Brightseed, Inc. (US) 2024-11-27 EP disclosed
CN-119013005-A Use and method for promoting mitochondrial mass and function enhancement 布莱特西德公司 2024-11-22 CN disclosed
WO-2024064102-A1 COMPOSITIONS AND METHODS FOR IMPROVING GUT PERMEABILITY BRIGHTSEED, INC. (US) 2024-03-28 WO disclosed
EP-4228667-A1 METHODS FOR REVERSING HEPATIC STEATOSIS Brightseed, Inc. (US) 2023-08-23 EP disclosed
CN-116568319-A Method for reversing hepatic steatosis 布莱特西德公司 2023-08-08 CN disclosed
WO-2023141427-A1 USES AND METHODS FOR PROMOTING INCREASED MITOCHONDRIAL MASS AND FUNCTION BRIGHTSEED, INC. (US) 2023-07-27 WO disclosed
EP-4048655-A1 RECOMBINANT CELL, EXTRACT, CONSUMABLE PRODUCT AND METHOD FOR PRODUCTION OF BIOACTIVE PLANT METABOLITE Brightseed, Inc. (US) 2022-08-31 EP disclosed
CN-114929033-A Methods for improving digestive health 布莱特西德公司 2022-08-19 CN disclosed
CN-114901630-A Recombinant cells, extracts, consumable products and methods for producing bioactive plant metabolites 布莱特西德公司 2022-08-12 CN disclosed
EP-4003060-A1 METHOD FOR IMPROVING DIGESTIVE HEALTH Brightseed, Inc. (US) 2022-06-01 EP disclosed
WO-2022081567-A1 METHODS FOR REVERSING HEPATIC STEATOSIS BRIGHTSEED, INC. (US) 2022-04-21 WO disclosed